U.S. Metals and Mining Stock News

RXO (RXO) stock has been under pressure after reports of rising transportation costs and large share reductions by some institutional holders, which have sharpened investor focus on margin resilience and balance sheet strength. See our latest analysis for RXO. RXO’s recent selloff, including a 1 day share price return of 11.07% decline and a 7 day share price return of 13.91% decline to US$13.74, comes after months of softer results. The 1 year total shareholder return of 30.64% decline shows...

The weak February U.S. jobs report, which showed a loss of 92,000 jobs and unemployment at 4.4%, triggered a 3.6% drop in Enova International (ENVA), highlighting investor concern around credit conditions and demand. See our latest analysis for Enova International. That jobs-driven drop comes after a tougher few weeks for the share price, with a 30 day share price return of a 14.6% decline and a year to date share price return of a 15.05% decline, even though the 1 year total shareholder...

Cabot (CBT) is back in focus after first quarter fiscal 2026 results that beat earnings estimates, but came with lower year over year sales and a trimmed adjusted EPS outlook. See our latest analysis for Cabot. The earnings beat has not stopped selling pressure in the short term, with a 1 day share price return of 5.40% decline and a 7 day share price return of 8.04% decline. At the same time, the 90 day share price return of 8.49% and 5 year total shareholder return of 46.88% point to a...

Septerna, Inc. recently reported positive Phase 1 results for SEP-631, an oral negative allosteric modulator of MRGPRX2, showing favorable tolerability, once-daily pharmacokinetics and clinical proof-of-mechanism in humans. The company’s decision to move SEP-631 into a Phase 2b trial for chronic spontaneous urticaria, alongside an open-label study in chronic inducible urticaria, highlights a focused push into difficult-to-treat allergic skin conditions. We will now examine how SEP-631’s...

Wingstop stock snapshot after recent performance Wingstop (WING) has been on many watchlists after a recent stretch of weaker returns, including a 3% decline in the latest session and double digit pullbacks over the past month and past 3 months. See our latest analysis for Wingstop. That 3% one day share price drop at around $229.17 caps a weaker run, with 7 day and 30 day share price returns of 11.69% and 13.20% declines, while the 5 year total shareholder return of 88.85% shows a very...

Boston Scientific (BSX) is under pressure after a series of securities class actions and investigations tied to its U.S. electrophysiology segment, where underperformance, reduced guidance and alleged misstatements have raised fresh questions for shareholders. See our latest analysis for Boston Scientific. At a share price of US$71.35, Boston Scientific has seen pressure build, with a 1 day share price return of 2.25% decline and a 90 day share price return of 23.97% decline, while the 3 year...

Why Stock Yards Bancorp is on investors’ radar today Stock Yards Bancorp (SYBT) has drawn fresh attention after recent share price moves, with the stock showing a month return near 9% decline and a past 3 months return near 4% decline. For investors tracking regional banks, those short term moves sit alongside a 1 year total return near 5% decline and longer term 3 year and 5 year total returns around 29%, supported by reported revenue of US$390.56m and net income of US$140.15m. See our...

Radian Group (RDN) has put an omnibus shelf registration in place covering common and preferred shares, debt securities, warrants, rights, stock purchase contracts, and units, providing the insurer with flexible access to future funding. See our latest analysis for Radian Group. Recent moves by Radian Group, including the Inigo acquisition and divestment of non core businesses, come as the shares trade at US$33.90 with a 1 year total shareholder return of 8.89% and a 3 year total shareholder...

Celldex Therapeutics (CLDX) has caught investor attention after presenting fresh Phase 2 and open label extension data for barzolvolimab in multiple urticaria indications at the AAAAI 2026 meeting in Philadelphia. See our latest analysis for Celldex Therapeutics. The latest barzolvolimab readouts arrive after a busy few weeks for Celldex, including multiple AAAAI presentations, completion of enrollment in the global Phase 3 CSU program and full year 2025 results that showed revenue of US$1.55...

If you are wondering whether Levi Strauss at around US$19.60 is a bargain or fully priced, you are not alone. The stock has been attracting attention from investors who care about what they are really paying for each dollar of fundamentals. The share price has seen a 11.6% decline over the last 7 days and is down 4.6% over 30 days and 5.9% year to date, yet it still shows a 22.3% return over 1 year and 33.0% over 3 years, with a 11.5% decline across 5 years. Recent headlines around Levi...

Plains All American Pipeline (PAA) recently raised its annualized distribution 10% to $1.67 per unit. The increase is tied to its fee-based, volume driven cash flows and coincides with rising oil prices amid heightened U.S. Iran tensions. See our latest analysis for Plains All American Pipeline. The distribution move comes as the unit price has been strong, with a 30 day share price return of 13.81% and a year to date share price return of 21.25%. The 5 year total shareholder return of...

Earlier this week, SM Energy Company completed pricing of an upsized US$1.00 billion private offering of 6.625% senior notes due 2034, issued at par, with proceeds earmarked mainly to fund a cash tender offer for up to US$750 million of higher‑coupon 8.375% notes maturing in 2028. This refinancing, coming soon after the Civitas merger, reshapes SM Energy’s debt profile by lowering coupon costs and pushing a portion of its maturities out to 2034 while targeting the acquired 2028 notes. Next,...

Nuvation Bio recently filed a US$125.34 million shelf registration for 21,462,599 shares of Class A common stock tied to an ESOP-related offering and reported fourth-quarter 2025 revenue of US$41.87 million with a reduced net loss of US$36.59 million. The company’s 2025 results reflected a sharp rise in annual revenue to US$62.90 million and a smaller full-year net loss of US$204.63 million, underpinned by the commercial launch of Ibtrozi and advancing late-stage oncology trials. With...

Recent performance snapshot Align Technology (ALGN) has seen mixed share performance recently, with a 0.9% decline over the past day and an 8.5% decline over the past week, while the past 3 months show a 10.4% gain. See our latest analysis for Align Technology. At a share price of US$174.00, Align’s recent 7 day and 30 day share price declines contrast with its positive year to date share price return and marginally positive 1 year total shareholder return. This suggests momentum has cooled...

If you are wondering whether UFP Technologies at around US$208.92 is still a quality opportunity or starting to look expensive, you are not alone. The share price is down about 0.8% over the last week, 21.9% over the last month and 6.5% year to date, although the 3 year and 5 year returns of 87.9% and 313.4% respectively show how much the stock has moved over a longer period. These recent moves sit against a backdrop of ongoing investor interest in the company and its role within the...

Dole plc reported past fourth-quarter and full-year 2025 results, with sales rising to US$2,366.16 million and US$9,172.91 million respectively, while quarterly net loss narrowed to US$2.66 million and full-year net income fell to US$51.32 million, alongside US$2.94 million of impairment and asset write-downs. Along with affirming a US$0.085 per-share quarterly dividend and completing a US$4.5 million share buyback of 300,000 shares, Dole’s weaker full-year earnings relative to the prior...

In February 2026, e.l.f. Beauty expanded beyond cosmetics and skin care by launching its first-ever hair products inspired by its viral Power Grip Primer, including a Power Grip Hair Gel Wand and Power Grip Gel Pomade. This move into haircare reflects e.l.f. Beauty’s effort to extend a successful hero formula into a new category, potentially deepening brand engagement across more parts of consumers’ routines. Next, we’ll examine how e.l.f. Beauty’s Power Grip–inspired haircare launch could...

NPK International Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$75.2 million and full-year net income improving to US$38.94 million, and issued full-year 2026 revenue guidance of US$305 million to US$325 million. The completion of a US$20.29 million share repurchase program alongside this earnings turnaround highlights management’s focus on capital returns and balance sheet discipline. Now we’ll consider how this earnings improvement and...

Tsakos Energy Navigation (NYSE:TNP) just closed out FY 2025 with Q4 revenue of US$222.1 million and basic EPS of US$1.70, setting a clear marker for how the year finished. Over the past few quarters, the company has seen revenue move from US$188.3 million and EPS of US$0.41 in Q4 2024 to US$197.1 million and EPS of US$1.04 in Q1 2025, US$193.3 million and EPS of US$0.67 in Q2 2025, and US$186.2 million and EPS of US$1.05 in Q3 2025. This gives investors a detailed view of how the top line and...

Why Motorola Solutions is on investors’ radar today Motorola Solutions (MSI) has drawn attention after a recent market move, with the stock’s short term performance prompting closer scrutiny of how its current valuation lines up with its earnings and cash generation profile. See our latest analysis for Motorola Solutions. Despite a recent 1-day share price return of a 1.37% decline and a 7-day share price return of a 4.46% decline, the latest share price of US$460.76 sits alongside a 30-day...

On 4 March 2026, Andersons reported fourth-quarter results that beat analyst expectations, led by strong Renewables and Agribusiness performance, while Vice President Anne G. Rex sold 2,624 shares worth about US$171,000 and other executives also reduced holdings. Analysts highlighted that record adjusted net income of about US$70 million and growing benefits from tax credits are bolstering the company’s long-term earnings profile, even as insider selling and policy sensitivity introduce...

In February 2026, Sezzle Inc. reported full-year 2025 results showing sales of US$450.28 million and net income of US$133.13 million, with basic earnings per share from continuing operations of US$3.93. The company also introduced fiscal 2026 guidance calling for total revenue growth of 25% to 30% and highlighted its evolution into a broader financial app with new mobile and AI-enabled features that could reshape how it competes in digital payments. Now we’ll examine how Sezzle’s strong...

Why JinkoSolar Holding (JKS) is on investors’ radar JinkoSolar Holding (JKS) has drawn attention after a period of mixed share performance, with the stock down over the past month and past 3 months yet showing a positive 1 year total return. See our latest analysis for JinkoSolar Holding. With the latest share price at US$23.34, JinkoSolar’s short term share price momentum has been weak, with recent declines contrasting with a positive 1 year total shareholder return. This points to mixed...

In recent days, Devon Energy has attracted heightened attention after analysts reaffirmed generally positive views following its Q4 revenue beat and continued progress on a Business Optimization Plan that is now about 85% complete. Analysts have also highlighted the company’s increased net proved reserves and potential expansion via a proposed merger with Coterra, underscoring its footprint in key U.S. shale basins. At the same time, Devon’s roughly 15% investment in geothermal developer...